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Abstract We compared Lon protease expression in murine
skeletal muscle of young and old, wild-type and Sod23/+ het-
erozygous mice, and studied Lon involvement in the accumula-
tion of damaged (oxidized) proteins. Lon protease protein levels
were lower in old and oxidatively challenged animals, and this
Lon de¢ciency was associated with increased levels of carbony-
lated proteins. We identi¢ed one of these proteins as aconitase,
and another as an aconitase fragmentation product, which we
can also generate in vitro by treating puri¢ed aconitase with
H2O2. These results imply that aging and oxidative stress
down-regulate Lon protease expression which, in turn, may be
responsible for the accumulation of damaged proteins, such as
aconitase, within mitochondria.
( 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The physiological functions and the substrate speci¢city of
the Lon protease in mammalian mitochondria are not well
understood. In yeast, loss of Lon function results in irregu-
larly shaped mitochondria in which the matrix space becomes
¢lled with electron-dense inclusion bodies thought to be ag-
gregated proteins [1,2]. New data from our laboratory indi-
cate that the Lon protease can selectively degrade oxidatively
modi¢ed aconitase at a much higher rate than unoxidized
control substrate, and may thus play an important role in
defending against the accumulation of oxidized proteins in
mitochondria [3^5]. Another proposed protein substrate for
Lon is the SP-22 mitochondrial protein [6]. This novel protein
has analogies with the thiol-speci¢c antioxidant gene (TSA)
product from S. cerevisiae and has the ability to scavenge
reactive oxygen species [7].
Aconitase plays a key function in cellular energy produc-
tion, and loss of its activity has a major impact on cellular
and organismal survival. Oxidative inactivation of aconitase
has been associated with decreased lifespan in Drosophila [8].
A decline in aconitase activity has also been described in other
abnormal situations, such as increased oxidative stress caused
by mitochondrial manganese superoxide dismutase (MnSOD)
de¢ciency [9], and in a number of neurodegenerative diseases,
including progressive supranuclear palsy [10], Friedreich’s
ataxia [11], and Huntington’s disease [12]. The hypothesis
that the Lon protease might have a role in defenses against
free radical damage inside mitochondria and that defects in its
production can lead to aging and disease [13,14] is in concord-
ance with high-density oligonucleotide array data ¢ndings
that lon mRNA levels decline about four-fold in ageing skel-
etal murine muscles, and that this phenomenon can be pre-
vented by caloric restriction [15].
In order to study regulation of the Lon protease during
aging and oxidative stress, we have chosen a murine model:
mitochondrial Sod23=þ (heterozygous B6-Sod26 tm16Cje
knockout) mice [9]. Because of their de¢ciency in antioxidant
(MnSOD) defenses [9], these mice su¡er a considerable
amount of oxygen radical damage [16] and have altered mi-
tochondrial function [17]. Both mitochondrial superoxide
dismutase gene (Sod2) knockout null mutants are lethal and
display a whole spectrum of disorders characteristic of patho-
logical ageing, such as neurodegeneration and myocardial in-
jury, at an early age [18,19]. The heterozygous Sod23=þ mice
are viable, but they exhibit a 50% decrease in MnSOD activity
and altered mitochondrial function [20], with accumulation of
8-hydroxydeoxyguanosine in the mt-DNA, and increased car-
bonyl groups in mitochondrial proteins [9]. In older animals,
an increased incidence of lymphoma, hydro-nephrosis and
pituitary adenoma has been reported [16].
2. Materials and methods
2.1. Materials
All chemicals and reagents were obtained from Sigma unless other-
wise speci¢ed. Puri¢ed aconitase was exposed to various concentra-
tions of hydrogen peroxide at 37‡C and pH 7.4 as previously de-
scribed [21], except that a shorter incubation time (30 min) was
used. Both the oxidized aconitase and the controls were extensively
dialyzed before use for Western blotting.
2.2. Animals
The line used in this study was B6-Sod26 tm16Cje [9,16,20]. The
Sod23=þ female mice and their wild-type, age-matched, controls were
fed ad libitum and maintained under barrier conditions on a 12-h
dark/light cycle. Mice aged 3 to 6 months (young animals) and 27
months (old animals) were killed by cervical dislocation, and the hind
limb muscles were immediately excised and frozen.
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2.3. Isolation of muscle proteins
The total hind leg muscle mass (1.5 g) was cut in small pieces,
homogenized with a glass homogenizer in the presence of 5 ml lysis
bu¡er [50 mM Tris^HCl pH 7.4, 150 mM NaCl, 1 mM PMSF, 1mM
EDTA, 5 Wg/ml Aprotinin, 5 Wg/ml Leupeptin, 1% Triton X-100, 1%
sodium deoxycholate (SDC), 0.1% sodium dodecyl sulfate (SDS)], and
centrifuged for 30 min in an Eppendorf tube at maximum speed
(14 000g) ; all these steps were performed at 4‡C. The supernatant
was saved as a whole tissue lysate, and stored at 380‡C for future
study.
2.4. Preparation of antibodies and Western blot analysis
The anti-Lon polyclonal antibody was raised in rabbits against a
synthetic peptide corresponding to amino acids 593^609 of the intact
human Lon protease, and it cross-reacts strongly with murine Lon. In
muscle extracts the anti-Lon polyclonal antibody recognized mostly
one protein band with an estimated molecular size of approximately
100 kDa, which corresponds to the molecular size previously de-
scribed for both the human and bovine Lon protease [22^24]. The
anti-aconitase polyclonal antibody was targeted to residues 767^780
of the C-terminus of human mitochondrial aconitase and cross-reacts
with both murine and porcine mitochondrial aconitase. The anti-aco-
nitase antibody speci¢cally recognized an 83-kDa band, the size of
intact mitochondrial aconitase. When oxidized aconitase (Sigma) was
used, a number of fragmentation and aggregation products were also
detected. ProSci produced both antibodies to our speci¢cations.
For Western blot detection we always used pooled samples from six
di¡erent animals from each group. We loaded 40 Wg of protein extract
for Lon protease detection, and 20 Wg of either protein extract or
puri¢ed oxidized aconitase (Sigma) for aconitase identi¢cation per
lane. After separation in 10^20% gradients gels, the proteins were
transferred onto BioRad PVDF membranes. The membranes were
incubated with the anti-Lon antibody at a 1:1000 dilution, or with
the anti-aconitase antibody at a 1:2000 dilution as indicated in the
¢gure legends. The secondary antibody in both cases was a goat anti-
rabbit IgG (Jackson ImmunoResearch Lab), and we used a 1:20 000
dilution. Next, antigens were detected by chemiluminesce with Amer-
sham’s ECL substrates. On all the Western blots, the membranes were
stripped and reprobed for cytochrome c (as a loading control for
mitochondrial proteins) and tubulin (total loading control).
2.5. Protein oxidation measurement
To detect oxidized proteins, we used the Oxyblot1 kit from Inter-
gen Company, based on derivatization of carbonyl groups in the
presence of 2,4-dinitrophenylhydrazine (DNPH), using a primary
antibody against dinitrophenylhydrazone (DNP) moieties for detec-
tion. We loaded 40 Wg protein in each lane. The blots were stripped
and reprobed with the anti-aconitase antibody to con¢rm the aconi-
tase identity.
3. Results and discussion
3.1. Changes in expression of the Lon protease in murine
muscle with aging and decreased MnSOD activity
Lon protease levels were lower in skeletal muscles of old
wild-type littermate control mice (Sod2þ=þ) and both young
and old heterozygous Sod23=þ mice (Fig. 1) when compared
with the young Sod2þ=þ. When we quanti¢ed our Western
blots (using IP lab gel software), the optical density of the
Lon protease band was four times lower in the old Sod2þ=þ,
two times lower in the young Sod23=þ group, and six times
lower in the old Sod3=þ group, in comparison with the young
Sod2þ=þ animals. These results suggest that a major Lon pro-
tease down-regulation is caused both by aging and by a re-
duction in (MnSOD) antioxidant defense systems, and that
these two e¡ects are additive.
The Lon protease is a major factor in maintaining mito-
chondrial integrity and continued mitochondrial biogenesis
[1,2,25]. We have previously shown that the Lon protease
degrades oxidized aconitase in cell culture systems, and that
cells with low levels of Lon protease accumulate oxidized (in-
active) aconitase and therefore have decreased total aconitase
activity [4,5]. Thus decreased Lon levels can lead to de¢cient
energy production and incomplete removal of oxidized pro-
teins, phenomena frequently described in skeletal muscles of
old or diseased individuals.
3.2. Mitochondrial aconitase levels are not changed by aging or
oxidative stress
Our Western blots showed no signi¢cant di¡erences in the
levels of aconitase between the four experimental groups (Fig.
2). However, in addition to the traditionally described 83-kDa
aconitase band, we were able to detect another aconitase frag-
ment of 40 kDa, as well as a number of less distinctive bands,
which form a smear in the old and Sod23=þ mice. The 40-kDa
fragment decreased with age and oxidative stress, whereas
other fragmentation products with molecular weights between
40 and 83 kDa increased with age and MnSOD de¢ciency.
As mentioned in the Section 1, a decline in aconitase activ-
ity has been previously measured in our Sod23=þ mouse mod-
el [9]. Since we detected almost equal levels of aconitase pro-
tein in the present studies, the previously described loss of
activity [9] must not have been caused by a decreased amount
of aconitase protein. No di¡erence in aconitase levels in the
liver of Sod2þ=þ and Sod23=þ was also previously described
[9]. We propose that partial replacement of normal aconitase
with inactive (oxidatively) damaged enzyme is the major cause
of diminished intracellular aconitase activity in the Sod23=þ
mouse.
3.3. Age and MnSOD down-regulation increase the levels
of carbonylated proteins
The total level of carbonylation increased both with aging
and with oxidative stress, to a 36% increase in old Sod2þ=þ
mice, an 80% increase in young Sod23=þ and a 250% increase
Lon Protease Protein Levels Decrease with
Aging and Oxidative Stress
Fig. 1. Mitochondrial Lon protease protein levels decrease with
aging and oxidative stress. Protein extracts were prepared from hind
leg muscles of young and old Sod2þ=þ and Sod23=þ mice. Samples
from six individual animals from each experimental group were
pooled together, as described in Section 2. The levels of Lon pro-
tease protein, cytochrome c (cyt c) and tubulin were determined by
Western blot, as described in Section 2. Each gel lane contained a
combined sample (40 Wg) from six di¡erent animals. The panel on
the right shows a summary of means and standard errors of Lon
protease levels from three di¡erent experiments, visualized by West-
ern blotting, and quanti¢ed by densitometry (IP Lab), in which re-
sults are reported as percentages of Lon expression in young
Sod2þ=þ animals.
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in the old Sod23=þ mice, when compared with young Sod2þ=þ
mice (Fig. 3A,B).
Using Western blot analysis of di¡erent carbonylated pro-
teins, we were able to identify at least seven distinct bands
(depending on the exposure time) corresponding to molecular
weights of 205 kDa, 130 kDa, 83 kDa, 70 kDa, 60 kDa, 50
kDa and 40 kDa (Fig. 3A). Each of these seven proteins had a
di¡erent pattern of expression in the four groups of animals
(Fig. 3B), with the higher molecular weight bands (205 kDa
and 130 kDa) being detectable only in the Sod23=þ animals,
suggesting that these bands could be formed by aggregation of
heavily damaged (oxidized) proteins. By stripping and reprob-
ing the gels of Fig. 3 with the anti-aconitase antibody (Fig.
4A), we con¢rmed that the 83-kDa band was aconitase, but
the 40-kDa band also cross-reacted with the primary anti-
body, allowing us to identify it as the aconitase fragmentation
product that we described in Fig. 2. In young Sod2þ=þ mice
the 40-kDa carbonylated fragment was approximately 50% of
the level of carbonylated aconitase (83 kDa; Fig. 4A). Inter-
estingly, the absolute levels of the 40-kDa band did not
change with age or Sod2 de¢ciency, but the relative amounts,
when compared with the level of carbonylated aconitase in the
same sample, actually decreased (to 12% of the level of car-
bonylated aconitase in old Sod23=þ mice). The identity of the
40-kDa protein fragment was also veri¢ed by in vitro H2O2
treatment of puri¢ed aconitase (Sigma; Fig. 4B). At lower
levels of peroxide treatment this fragment was not seen, but
it appeared at H2O2 concentrations above 2 mM. In agree-
ment with our observations in murine muscles, this fragment
was not detected at very high oxidant treatment (20 mM
H2O2), probably because of further fragmentation or loss of
antigenicity.
We measured very signi¢cant di¡erences in the levels of
oxidized aconitase (the 83-kDa band) in the carbonyl blots
of the various groups of animals (Fig. 3A,B). Carbonylated
aconitase accumulated in old Sod2þ=þ mice (almost twice as
much as in the young animals) and in both the young
Sod23=þ and old Sod23=þ (three and four times more, respec-
tively) mice when compared to the levels in the young
Sod2þ=þ mice. This accumulation of oxidized aconitase is con-
sistent with previously published reports, suggesting that aco-
nitase is a selective target for oxidation [8]. However, aconi-
tase was not the only protein that was modi¢ed and it always
accounted for less than 50% of the total carbonyl content in
our quanti¢cations (Fig. 3B).
In conclusion, we propose that a decline in Lon protease
expression is possibly a major signi¢cant factor in the accu-
mulation of oxidized mitochondrial aconitase in old and ox-
idatively challenged animals. Since accumulation of damaged
proteins can lead to mitochondrial dysfunction, we also pro-
pose that diminished Lon activity plays a signi¢cant role in
the development of mitochondrial pathology during aging. In
addition, a decrease in mitochondrial biogenesis, the other
Fig. 3. Carbonylated muscle proteins in young and old, normal and
Sod23=þ mice. Oxidized (carbonylated) muscle proteins (40 Wg/lane)
were identi¢ed by derivatization of carbonyl groups in the presence
of DNPH, and Western blotting using anti-DNP antibodies (for de-
tails see Section 2). A: Varying exposure times allowed the di¡eren-
tiation of seven carbonylated proteins, the most prominent band
corresponding to a molecular weight of 83 kDa. B: Densitometric
quanti¢cation of three independent experiments. The levels of the
most distinctive bands were calculated as percentages (means and
standard errors) of the 83-kDa band in the young wild-type ani-
mals.
Fig. 4. Carbonylated aconitase and aconitase fragmentation product
identi¢cation. A: After carbonylated protein detection (see Fig. 3),
the membranes were chemically stripped and reprobed with primary
anti-aconitase antibodies. Only two di¡erent products, with molecu-
lar weights of 83 kDa and 40 kDa, were identi¢ed in repeated ex-
periments. B: Puri¢ed aconitase (0.33 mg/ml) was incubated with
H2O2 at the concentrations indicated for 30 min at 37‡, as described
in Section 2. Residual peroxide was then removed by dialysis, and
aconitase (both oxidized and control) was used for Western blot de-
tection (primary anti-aconitase antibody). The blot shown in B was
repeated several times with similar results.
Fig. 2. Mitochondrial aconitase protein levels remain unchanged
with aging and oxidative stress. The content of aconitase in total
muscle protein samples from the four groups of animals was esti-
mated by Western blotting, as described in Section 2, in three inde-
pendent experiments. The blots were quanti¢ed by densitometry us-
ing IP Lab software, and the results (means and standard errors)
are expressed as percentages of total aconitase content in young,
wild-type animals. Tubulin was used as a loading control. Each lane
contained 20 Wg protein coming from six individual mice per each
experimental group.
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proposed e¡ect of Lon de¢ciency in mammalian cells [1,25],
would render muscle ¢bers unable to produce enough new
mitochondria to replace the old and damaged ones, and
would lead to impaired energy metabolism in muscle tissues.
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